Skip to main content

AstraZeneca CEO’s pay package contested by investors

The Investment Association, an influential investors group from the City of London, has come out against the proposed annual pay package of AstraZeneca Chief Executive Pascal Soriot, which could potentially net him some $25 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.